Cigna's partnership with $LLY (+1,37%) and $NOVO B (+3,18%) to cap co-payments at $200 for Zepbound and Wegovy (i.e. $400 cheaper) has 0 significance for $HIMS (+8,82%) . Since Hims is not in the insurance business and others are willing to sell it for $0!
